Last reviewed · How we verify
NCT06909968
Identification of Palliative Care Needs and Prognostic Factors of Survival in Tailoring Appropriate Interventions in Advanced Oncological, Renal and Pulmonary Diseases
trial testing palliative care in Cancer in 178 participants. Completed in 17 October 2025.
26 February 2025
Quick facts
| Lead sponsor | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 178 |
| Start date | 14 December 2020 |
| Primary completion | 26 February 2025 |
| Estimated completion | 17 October 2025 |
| Sites | 5 locations across Italy |
Drugs / interventions tested
- palliative care — full drug profile →
Conditions studied
- Cancer — all drugs for Cancer →
- Chronic Renal Failure — all drugs for Chronic Renal Failure →
- Chronic Obstructive Pulmonary Disease — all drugs for Chronic Obstructive Pulmonary Disease →
- Idiopathic Pulmonary Fibrosis — all drugs for Idiopathic Pulmonary Fibrosis →
Sponsor
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS — full company profile →
Who can join
18 and older, any sex, with Cancer or Chronic Renal Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective observational study done on 3 patient populations (cancer, chronic pulmonary and renal disease). All patients will be treated and monitored according to the local clinical practice. No additional procedures/patient visits in comparison with the usual clinical practice are planned for the study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06909968
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of palliative care
Trials testing the same drug.
- NCT03915743 — Advance Care Planning Individualised Approach and Research Projec · NA · terminated
- NCT03724097 — Identification of Molecular Biomarkers for Cancer Target Therapy Efficacy · unknown
- NCT01828775 — Palliative Care Intervention in Improving Quality of Life, Psychological Distress, and Communication in Patients With So · NA · completed
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS trials
Trials by the same sponsor.
- NCT06522919 — Sequential Immunochemotherapy Treatment with Pembrolizumab Plus Dendritic Cell (DC) Vaccine Followed by Trifluridine/Tip · Phase 2 · recruiting
- NCT06390241 — Avidination for RadionuclideTHerapy in Nonpalpable Breast Cancer · Phase 1 · terminated
- NCT05861336 — GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic Cancer · Phase 2 · withdrawn
- NCT03454750 — Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC) · Phase 2 · completed
- NCT04826458 — Clinical Study Comparing Different Strategies to Increase Adherence to Oral Therapies in Oncohematology · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06909968 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- Last refreshed: 3 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06909968.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing